Question 1

What are the specific benefits of the TCCA regimen for my type of cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine clinical trial (NCT06060782). Contact the study team or your healthcare provider for specific answers.

What this study is about